The White House is Strongly Supporting the Growth of Telehealth August 24, 2020 - Baystreet.ca The Trump Administration is asking private insurers to expand telehealth benefits to its members. In fact, at a virtual "Roundtable Discussion on Embracing Technology and Telehealth," the White House launched the Pledge to Embrace Technology to Advance America's Health to assure people that "telehealth is here to stay," according to a White House release. In addition, in early August, the Trump Administration signed an executive order to extend telehealth services offered to Medicare beneficiaries. "The onset of COVID-19 has challenged our Nation and the world to rethink the future of healthcare delivery. The Trump Administration is advancing our Nation's health through a shared public and private sector commitment to emerging technologies that make high quality healthcare more accessible for all Americans," U.S. Chief Technology Officer Michael Kratsios said. With broad support from the White House, some of the top telehealth companies to watch include CloudMD Software & Services Inc. (TSXV:DOC) (OTCQB:DOCRF), Teladoc Health Inc. (NYSE:TDOC), CVS Health Corp. (NYSE:CVS), Livongo Health Inc. (NASDAQ:LVGO), and Titan Medical Inc. (NASDAQ:TMDI). CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF) BREAKING NEWS: CloudMD Software & Services Inc., a telehealth company revolutionizing the delivery of healthcare to patients, is excited to announce that it has entered into a Binding Term Sheet ("Term Sheet") to acquire Re:Function Health Group Inc., a leading rehabilitation clinic network, with 7 clinics and 35 specialists and allied health professionals across British Columbia. This acquisition represents a significant addition to the depth and spectrum of healthcare services provided by the CloudMD platform. With Re:Function, CloudMD's network will include 14 clinics servicing approximately 500,000 patients. Patients and payors (insurers and enterprise clients) are demanding a single, integrated solution for their healthcare needs and now CloudMD will offer exactly that. Continuity of care and a patient centric model can only be achieved if the entire care team (all healthcare professionals) are empowering the patient with a comprehensive view of their healthcare record and in order to do so, the fragmentation of data needs to be addressed. CloudMD will introduce its suite of health technology solutions and integrated platform of telehealth and electronic medical records software to the Re:Function clinics in order to achieve this. Re:Function is a state-of-the-art rehabilitation center built by like-minded health professionals offering superior patient focused care, with a longitudinal approach to healthcare delivery. The practice is made up of four key rehabilitation pillars, Re:Build (physio), Re:Think (counselling), Re:View (medlegal) and Re:Tool (occupational), and a team of specialists including: Occupational Therapists, Physiotherapists, Kinesiologists, Psychologists, Psychiatrists and Counsellors. Founders and the group's leading Occupational Therapists, Ralph Cheesman and Mike Smith will be joining CloudMD to lead the continued expansion of allied health services across North America, and together will provide a multidisciplinary, team-based approach to treatment. The acquisition is mutually important in the shared vision to disrupt the current healthcare delivery system and to provide continuity of care across multiple verticals to ensure exceptional patient care. CloudMD will integrate its telemedicine solutions throughout the clinics, layering on additional allied health and specialist functions to the platform. CloudMD's registered users will now have access to primary care Doctors, specialists, and a network of mental, occupational and physical health specialists. The Re:Function team also gives CloudMD's network of primary care physicians options to give patients referrals to extended care. The acquisition will be immediately accretive to CloudMD as the Re:Function group of clinics generated approximately $5.8 million in revenues with earnings before interest, taxes, depreciation and amortization (EBITDA) margins exceeding 19% over the last fiscal year ending January, 2020. Essam Hamza, CEO of CloudMD commented, "I am thrilled with our acquisition of Re:Function which is synergistic across all aspects of our business. This acquisition continues to validate CloudMD's approach of having a business built by healthcare professionals, providing longitudinal, patient centric care including primary care, chronic care, specialists and mental health support. Team based delivery of healthcare is the future and having Re:Function's team of experts to help us continue to expand our telemedicine platform across North America is extremely valuable. We are excited to have Ralph and Mike join the team and feel that this is a transformational partnership for us and we look forward to working closely with them to provide better care for our combined rapidly growing network of patients." Ralph Cheesman, CEO of Re:Function commented, "Re:Function Health Group has a mandate to provide cohesive multidisciplinary healthcare services to our clients/patients and customers. We are excited to join and align with CloudMD's vision of future healthcare delivery. Our allied healthcare services assist clients/patients with chronic or comorbid impairments to effectively improve their health. We are looking forward to work with CloudMD to provide efficient and comprehensive healthcare across North America." Other related developments from around the markets include: Teladoc Health Inc. (NYSE:TDOC) the global leader in virtual care, recognized top hospitals and health systems with the Telehealth Innovation Awards for achievements in advancing virtual care worldwide at the 14th Telehealth Innovation Forum. This highly-regarded annual event, held virtually this year, gathered more than 3,500 healthcare leaders to discuss growth strategies and the future of virtual care. The Telehealth Innovation Awards were established to recognize healthcare providers who have successfully implemented an innovative approach to their virtual care strategies to advance patient care. While each award category typically highlights telehealth's ability to transform delivery models for organizations of all sizes, the insights collected from this year also highlight the vital role virtual care has in extending access to healthcare during the COVID-19 pandemic. "Now, more than ever, healthcare providers are facing increased challenges to delivering care," said Joseph DeVivo, president, hospital and health systems at Teladoc Health. "COVID has exponentially increased the number of hospitals and health systems utilizing virtual care platforms as well as expanded the use cases for those who had already deployed a virtual care platform. Through leadership and innovation, this year's Telehealth Innovation Award winners are delivering patient care from post-op, to neonatology, to stroke and more, meeting patients where they are with excellence in care. We applaud all the award recipients for being at the forefront of healthcare delivery." CVS Health Corp. (NYSE:CVS) expanded its COVID-19 testing program by deploying 77 additional test sites at select CVS Pharmacy drive-thru locations across Florida. The opening of these new test sites on Friday, August 21 add to the 221 locations previously opened in Florida. The 77 additional test sites opening across the state this week are among the more than 1,900 locations CVS Health has opened since May and expand the company's overall testing capacity. In addition to increasing the number of drive-thru sites, CVS Health has expanded its network of independent third-party lab partners in an effort to help improve turnaround time for the delivery of test results. Given the steps CVS Health has taken, the majority of test results across the country will generally be available within 2 to 5 days. "Our national scale and local community presence enable us to uniquely expand people's access to safe and effective COVID-19 testing options and respond to a need for increased testing capacity," said Emmanuel Kolady, Senior Vice President, CVS Health. "We remain grateful to our frontline colleagues who make these testing sites possible and whose dedication has allowed us to keep our stores and MinuteClinics open for customers seeking supplies and patients who need care." Livongo Health Inc. (NASDAQ:LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter ended June 30, 2020. "Livongo entered 2020 with significant momentum and our strong results continued during the second quarter," said Zane Burke, Chief Executive Officer of Livongo. "Innovative employers and health plans are choosing Livongo due to our leading Consumer Directed Virtual Care model and our ability to deliver significant clinical and financial improvements through a one-to-many approach. As we experience the further adoption of virtual health and remote monitoring technologies as the new standard of care, Livongo continues to build on its leadership position." Titan Medical Inc. (NASDAQ:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces financial results for the three and six months ended June 30, 2020. All financial results are prepared in accordance with International Accounting Standards 34 on a basis consistent with the Company's 2019 annual financial statements and are reported in U.S. dollars, unless otherwise stated. David McNally, President and CEO of Titan, said, "The most significant event of the first half of 2020 was the execution of a license agreement, a development and license agreement and a senior secured note with Medtronic plc, which we announced on June 4. We are honored to have secured this relationship based on the value demonstrated in our intellectual property and technology, and the confidence in our technical know-how in single-port robotic surgery to develop, over the course of the next 12 months, technologies for the mutual benefit of each company." Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. CloudMD Software & Services Inc. has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of CloudMD Software & Services Inc. Please click here for full disclaimer. Contact Information: 2818047972 ty@wallstreetnation.com
The White House is Strongly Supporting the Growth of Telehealth August 24, 2020 - Baystreet.ca The Trump Administration is asking private insurers to expand telehealth benefits to its members. In fact, at a virtual "Roundtable Discussion on Embracing Technology and Telehealth," the White House launched the Pledge to Embrace Technology to Advance America's Health to assure people that "telehealth is here to stay," according to a White House release. In addition, in early August, the Trump Administration signed an executive order to extend telehealth services offered to Medicare beneficiaries. "The onset of COVID-19 has challenged our Nation and the world to rethink the future of healthcare delivery. The Trump Administration is advancing our Nation's health through a shared public and private sector commitment to emerging technologies that make high quality healthcare more accessible for all Americans," U.S. Chief Technology Officer Michael Kratsios said. With broad support from the White House, some of the top telehealth companies to watch include CloudMD Software & Services Inc. (TSXV:DOC) (OTCQB:DOCRF), Teladoc Health Inc. (NYSE:TDOC), CVS Health Corp. (NYSE:CVS), Livongo Health Inc. (NASDAQ:LVGO), and Titan Medical Inc. (NASDAQ:TMDI). CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF) BREAKING NEWS: CloudMD Software & Services Inc., a telehealth company revolutionizing the delivery of healthcare to patients, is excited to announce that it has entered into a Binding Term Sheet ("Term Sheet") to acquire Re:Function Health Group Inc., a leading rehabilitation clinic network, with 7 clinics and 35 specialists and allied health professionals across British Columbia. This acquisition represents a significant addition to the depth and spectrum of healthcare services provided by the CloudMD platform. With Re:Function, CloudMD's network will include 14 clinics servicing approximately 500,000 patients. Patients and payors (insurers and enterprise clients) are demanding a single, integrated solution for their healthcare needs and now CloudMD will offer exactly that. Continuity of care and a patient centric model can only be achieved if the entire care team (all healthcare professionals) are empowering the patient with a comprehensive view of their healthcare record and in order to do so, the fragmentation of data needs to be addressed. CloudMD will introduce its suite of health technology solutions and integrated platform of telehealth and electronic medical records software to the Re:Function clinics in order to achieve this. Re:Function is a state-of-the-art rehabilitation center built by like-minded health professionals offering superior patient focused care, with a longitudinal approach to healthcare delivery. The practice is made up of four key rehabilitation pillars, Re:Build (physio), Re:Think (counselling), Re:View (medlegal) and Re:Tool (occupational), and a team of specialists including: Occupational Therapists, Physiotherapists, Kinesiologists, Psychologists, Psychiatrists and Counsellors. Founders and the group's leading Occupational Therapists, Ralph Cheesman and Mike Smith will be joining CloudMD to lead the continued expansion of allied health services across North America, and together will provide a multidisciplinary, team-based approach to treatment. The acquisition is mutually important in the shared vision to disrupt the current healthcare delivery system and to provide continuity of care across multiple verticals to ensure exceptional patient care. CloudMD will integrate its telemedicine solutions throughout the clinics, layering on additional allied health and specialist functions to the platform. CloudMD's registered users will now have access to primary care Doctors, specialists, and a network of mental, occupational and physical health specialists. The Re:Function team also gives CloudMD's network of primary care physicians options to give patients referrals to extended care. The acquisition will be immediately accretive to CloudMD as the Re:Function group of clinics generated approximately $5.8 million in revenues with earnings before interest, taxes, depreciation and amortization (EBITDA) margins exceeding 19% over the last fiscal year ending January, 2020. Essam Hamza, CEO of CloudMD commented, "I am thrilled with our acquisition of Re:Function which is synergistic across all aspects of our business. This acquisition continues to validate CloudMD's approach of having a business built by healthcare professionals, providing longitudinal, patient centric care including primary care, chronic care, specialists and mental health support. Team based delivery of healthcare is the future and having Re:Function's team of experts to help us continue to expand our telemedicine platform across North America is extremely valuable. We are excited to have Ralph and Mike join the team and feel that this is a transformational partnership for us and we look forward to working closely with them to provide better care for our combined rapidly growing network of patients." Ralph Cheesman, CEO of Re:Function commented, "Re:Function Health Group has a mandate to provide cohesive multidisciplinary healthcare services to our clients/patients and customers. We are excited to join and align with CloudMD's vision of future healthcare delivery. Our allied healthcare services assist clients/patients with chronic or comorbid impairments to effectively improve their health. We are looking forward to work with CloudMD to provide efficient and comprehensive healthcare across North America." Other related developments from around the markets include: Teladoc Health Inc. (NYSE:TDOC) the global leader in virtual care, recognized top hospitals and health systems with the Telehealth Innovation Awards for achievements in advancing virtual care worldwide at the 14th Telehealth Innovation Forum. This highly-regarded annual event, held virtually this year, gathered more than 3,500 healthcare leaders to discuss growth strategies and the future of virtual care. The Telehealth Innovation Awards were established to recognize healthcare providers who have successfully implemented an innovative approach to their virtual care strategies to advance patient care. While each award category typically highlights telehealth's ability to transform delivery models for organizations of all sizes, the insights collected from this year also highlight the vital role virtual care has in extending access to healthcare during the COVID-19 pandemic. "Now, more than ever, healthcare providers are facing increased challenges to delivering care," said Joseph DeVivo, president, hospital and health systems at Teladoc Health. "COVID has exponentially increased the number of hospitals and health systems utilizing virtual care platforms as well as expanded the use cases for those who had already deployed a virtual care platform. Through leadership and innovation, this year's Telehealth Innovation Award winners are delivering patient care from post-op, to neonatology, to stroke and more, meeting patients where they are with excellence in care. We applaud all the award recipients for being at the forefront of healthcare delivery." CVS Health Corp. (NYSE:CVS) expanded its COVID-19 testing program by deploying 77 additional test sites at select CVS Pharmacy drive-thru locations across Florida. The opening of these new test sites on Friday, August 21 add to the 221 locations previously opened in Florida. The 77 additional test sites opening across the state this week are among the more than 1,900 locations CVS Health has opened since May and expand the company's overall testing capacity. In addition to increasing the number of drive-thru sites, CVS Health has expanded its network of independent third-party lab partners in an effort to help improve turnaround time for the delivery of test results. Given the steps CVS Health has taken, the majority of test results across the country will generally be available within 2 to 5 days. "Our national scale and local community presence enable us to uniquely expand people's access to safe and effective COVID-19 testing options and respond to a need for increased testing capacity," said Emmanuel Kolady, Senior Vice President, CVS Health. "We remain grateful to our frontline colleagues who make these testing sites possible and whose dedication has allowed us to keep our stores and MinuteClinics open for customers seeking supplies and patients who need care." Livongo Health Inc. (NASDAQ:LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter ended June 30, 2020. "Livongo entered 2020 with significant momentum and our strong results continued during the second quarter," said Zane Burke, Chief Executive Officer of Livongo. "Innovative employers and health plans are choosing Livongo due to our leading Consumer Directed Virtual Care model and our ability to deliver significant clinical and financial improvements through a one-to-many approach. As we experience the further adoption of virtual health and remote monitoring technologies as the new standard of care, Livongo continues to build on its leadership position." Titan Medical Inc. (NASDAQ:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces financial results for the three and six months ended June 30, 2020. All financial results are prepared in accordance with International Accounting Standards 34 on a basis consistent with the Company's 2019 annual financial statements and are reported in U.S. dollars, unless otherwise stated. David McNally, President and CEO of Titan, said, "The most significant event of the first half of 2020 was the execution of a license agreement, a development and license agreement and a senior secured note with Medtronic plc, which we announced on June 4. We are honored to have secured this relationship based on the value demonstrated in our intellectual property and technology, and the confidence in our technical know-how in single-port robotic surgery to develop, over the course of the next 12 months, technologies for the mutual benefit of each company." Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. CloudMD Software & Services Inc. has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of CloudMD Software & Services Inc. Please click here for full disclaimer. Contact Information: 2818047972 ty@wallstreetnation.com